DocDollars

Ipsen Bioscience Inc.

MA · United States · Reporting entity ID 100000005526

Total reported 2019–2025
$41.0M
#195 of 2,960 reporting companies — 0% of all reported industry payments
$8.28M in general payments across 436 records, plus $32.7M in research funding across 4,571 records.

How it breaks down

General payments $8,279,245
Research funding $32,736,166

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Ipsen Bioscience Inc. reported $41.0M to US doctors and teaching hospitals from 2019 to 2025, ranking #195 of 2,960 reporting companies. 80% of that was research funding and 20% general payments such as consulting, speaking, food and travel. 436 general payment records and 4,571 research records were filed.

Common questions about Ipsen Bioscience Inc.

How much has Ipsen Bioscience Inc. paid US doctors?

Ipsen Bioscience Inc. reported $41,015,411 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $8,279,245 in general payments, $32,736,166 in research funding.

How does Ipsen Bioscience Inc. rank among drug and device companies?

It ranks #195 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Ipsen Bioscience Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.